Who is pausing immunosuppressive medication for COVID-19 vaccination? Results of an exploratory observational trial
2022-06-22 | journal article; research paper. A publication with affiliation to the University of Göttingen.
Jump to: Cite & Linked | Documents & Media | Details | Version history
Cite this publication
Who is pausing immunosuppressive medication for COVID-19 vaccination? Results of an exploratory observational trial
Schröder, D. ; Heinemann, S. ; Heesen, G.; Klawonn, F.; Mikuteit, M.; Niewolik, J. & Steffens, S. et al. (2022)
European journal of medical research, 27(1) art. 97. DOI: https://doi.org/10.1186/s40001-022-00727-7
Documents & Media
Details
- Authors
- Schröder, Dominik ; Heinemann, Stephanie ; Heesen, Gloria; Klawonn, Frank; Mikuteit, Marie; Niewolik, Jacqueline; Steffens, Sandra; Behrens, Georg; Jablonka, Alexandra; Müller, Frank
- Abstract
- The influence of immunosuppressive therapy on immunogenicity after COVID-19 vaccination remains unclear. This study surveys patients who receive immunosuppressive therapy about whether or not they paused their immunosuppressive medication while receiving SARS-CoV-2 vaccination.
- Issue Date
- 22-June-2022
- Journal
- European journal of medical research
- Project
- DEFEnse Against COVID-19 STudy
- Organization
- Institut für Allgemeinmedizin
- ISSN
- 2047-783X
- eISSN
- 2047-783X
- Language
- English
- Sponsor
- Open-Access-Publikationsfonds 2022
